Literature DB >> 2053793

Occurrence, clinical manifestations, and prognosis of Guillain-Barré syndrome.

H Rantala1, M Uhari, M Niemelä.   

Abstract

In order to obtain more information on the incidence of Guillain-Barré syndrome and recent developments in its prognosis, we analysed the severity and prognosis of Guillain-Barré syndrome in children diagnosed and treated during the years 1980-6 throughout Finland. The criteria for Guillain-Barré syndrome were fulfilled in 14 boys and 13 girls. The mean annual number of cases of Guillain-Barré syndrome was thus 3.9, giving a mean annual incidence of 0.38/100,000 of population under 15 years of age (95% confidence intervals 0.25 to 0.56/100,000). The incidence of Guillain-Barré syndrome causing permanent neurological defects in children under 15 years of age was 1.4/10 million annually (95% confidence intervals 0.035 to 7.8/10 million). Our figures appeared to be one fourth to a half of that reported earlier in children and even lower than those in adults. Although there were no deaths among our patients, mortality from Guillain-Barré syndrome seems to have remained similar for the last 20 years despite current awareness of the possibility of cardiac arrest and respiratory failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2053793      PMCID: PMC1793142          DOI: 10.1136/adc.66.6.706

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  The Guillain-Barré syndrome in childhood. A comprehensive review, including observations on 19 additional cases.

Authors:  L D Markland; H D Riley
Journal:  Clin Pediatr (Phila)       Date:  1967-03       Impact factor: 1.168

2.  The Landry-Guillain-Barré-Strohl syndrome in childhood.

Authors:  G W Paulson
Journal:  Dev Med Child Neurol       Date:  1970-10       Impact factor: 5.449

3.  Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy.

Authors:  R J Greenwood; J Newsom-Davis; R A Hughes; S Aslan; A N Bowden; D W Chadwick; N S Gordon; D L McLellan; P Millac; R B Stott
Journal:  Lancet       Date:  1984-04-21       Impact factor: 79.321

4.  Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy.

Authors:  P O Osterman; J Fagius; G Lundemo; P Pihlstedt; R Pirskanen; A Sidén; J Säfwenberg
Journal:  Lancet       Date:  1984-12-08       Impact factor: 79.321

5.  Guillain-Barré syndrome: a 42-year epidemiologic and clinical study.

Authors:  R H Kennedy; M A Danielson; D W Mulder; L T Kurland
Journal:  Mayo Clin Proc       Date:  1978-02       Impact factor: 7.616

6.  The Guillain-Barré syndrome epidemiologic and clinical features.

Authors:  J E Hogg; D E Kobrin; B S Schoenberg
Journal:  J Chronic Dis       Date:  1979

7.  Polyneuropathy in childhood.

Authors:  O B Evans
Journal:  Pediatrics       Date:  1979-07       Impact factor: 7.124

8.  Prognosis in severe Guillain-Barré syndrome.

Authors:  G F Cole; D J Matthew
Journal:  Arch Dis Child       Date:  1987-03       Impact factor: 3.791

9.  Controlled trial prednisolone in acute polyneuropathy.

Authors:  R A Hughes; J M Newsom-Davis; G D Perkin; J M Pierce
Journal:  Lancet       Date:  1978-10-07       Impact factor: 79.321

10.  Guillain-Barré syndrome in Western Australia, 1980-1985.

Authors:  G J Hankey
Journal:  Med J Aust       Date:  1987-02-02       Impact factor: 7.738

View more
  10 in total

1.  Lesson of the week: A painful hip as a presentation of Guillain-Barré syndrome in children.

Authors:  T Tang; C Noble-Jamieson
Journal:  BMJ       Date:  2001-01-20

2.  Assessment of autonomic dysfunction in childhood guillain-barré syndrome.

Authors:  Mahmood Samadi; Babak Kazemi; Sona Golzari Oskoui; Mohammad Barzegar
Journal:  J Cardiovasc Thorac Res       Date:  2013-10-05

3.  Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.

Authors:  R Korinthenberg; J S Mönting
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

4.  Outcome in childhood Guillain-Barré syndrome.

Authors:  Veena Kalra; Naveen Sankhyan; Suvasini Sharma; Sheffali Gulati; Rama Choudhry; Benu Dhawan
Journal:  Indian J Pediatr       Date:  2009-04-16       Impact factor: 1.967

5.  Videofluoroscopic evaluation of patients with Guillain-Barré syndrome.

Authors:  M Y Chen; P D Donofrio; M G Frederick; D J Ott; L A Pikna
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

Review 6.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

7.  Epidemiology of Guillain-Barré syndrome in Finland 2004-2014.

Authors:  Jussi O T Sipilä; Merja Soilu-Hänninen; Jori O Ruuskanen; Päivi Rautava; Ville Kytö
Journal:  J Peripher Nerv Syst       Date:  2017-11-15       Impact factor: 3.494

8.  The disease burden associated with Campylobacter spp. in Germany, 2014.

Authors:  Julia Lackner; Michael Weiss; Christine Müller-Graf; Matthias Greiner
Journal:  PLoS One       Date:  2019-05-15       Impact factor: 3.240

9.  Campylobacter infection as a trigger for Guillain-Barré syndrome in Egypt.

Authors:  Thomas F Wierzba; Ibrahim Adib Abdel-Messih; Bayoumi Gharib; Shahida Baqar; Amina Hendaui; Ibrahim Khalil; Tarek A Omar; Hamed E Khayat; Shannon D Putnam; John W Sanders; Lai-King Ng; Lawrence J Price; Daniel A Scott; Robert R Frenck
Journal:  PLoS One       Date:  2008-11-12       Impact factor: 3.240

10.  Guillain-Barré syndrome risk among individuals infected with Zika virus: a multi-country assessment.

Authors:  Luis Mier-Y-Teran-Romero; Mark J Delorey; James J Sejvar; Michael A Johansson
Journal:  BMC Med       Date:  2018-05-15       Impact factor: 8.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.